Staging using the AJCC cancer staging manual that describes the prognosis of the specific disease at a given time in the patient’s cancer journey.

Additional specimens provided on a colorectal metastectomy histopthology request, e.g. lymph nodes

Additional specimens provided on a colorectal histopthology request, e.g. lymph nodes.

Administration details relevant to a pathology report form.

Administration details relevant to a pathology request form.

Administration details relevant to a radiation oncology treatment summary form.

Relevant information about diagnostic tests on a specimen which are supplementary to the main test.

Relevant information about diagnostic tests on a breast specimen which are supplementary to the main test.

Relevant information about diagnostic tests on a soft tissue specimen which are supplementary to the main test.

Relevant information about diagnostic tests on a soft tissue specimen which are supplementary to the main test.

A supplementary diagnostic test on a specimen, which is described as an ‘Other ancillary study’ on the form.

The macroscopic appearance of the cut surface of a resection specimen. This should note areas of necrosis, haemorrhage or any variation in appearance.

Tests used to measure substances in specimens.

Details about an anatomical location or body part.

The main identifying details of a body site including the body structure and laterality.

The measured or calculated surface area of the patient’s body.

A section used to support compositions for breast cancers.

The clinical stage classification of distant metastasis, based on patient history, physical examination, and any imaging done before initiation of treatment.

The clinical stage classification of regional lymph nodes, based on patient history, physical examination, and any imaging done before initiation of treatment.

The clinical stage classification of the primary tumour, based on patient history, physical examination, and any imaging done before initiations of treatment.

The administrative details about a care plan.

Clinical information about the patient, as documented on a colorectal small diagnostic request.

Relevant clinical information about the patient in a soft tissue biopsy histopathology composition.

Clinical TNM staging for invasive carcinoma of the breast, and ductal carcinoma in situ of the breast.

Clinical TNM staging using the AJCC staging manual.

Clinical TNM staging for colorectal cancers, including adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous carcinomas of the colon (see chapter 20 of AJCC, 8th edition).

An observation made about the patient by clinical assessment.

The result of a clinical observation made on the patient, e.g. a sign, symptom, or assessment.

Relevant information about the patient’s previous conditions.

The suspected behaviour of the specimen, as determined by the clinician (e.g. surgeon).

The suspected behaviour of the breast specimen, as determined by the clinician (e.g. surgeon).

The suspected origin of the tumour, e.g. new primary, local recurrence, distant metastasis.

Relevant clinical information about the patient in a breast histopathology composition.

Relevant clinical information about the patient in a breast resection histopathology composition.

Relevant clinical information about the patient in a breast small diagnostic histopathology composition.

Clinical information about the patient, as documented on a colorectal metastectomy histopathology form.

Relevant clinical information about the patient, as documented on a colorectal histopathology request.

Clinical information about the patient, as documented on a colorectal resection histopathology report.

Relevant clinical information about the patient in a soft tissue histopathology composition.

The status of the tissue on the margin of a resected specimen as specified by the clinician (eg surgeon).

A clinical measurement involves the measurement of the body’s functions or properties, e.g. body temperature, pulse rate, blood pressure, weight, height.

Relevant clinical symptoms or findings that the patient presents with, e.g. breast lump.

The AJCC residual tumour category, as assessed by the clinician (e.g. surgeon).

Clinical TNM staging for colorectal cancers, including adenocarcinomas, high-grade neuroendocrine carcinomas, and squamous carcinomas of the colon.

An indicator of whether a patient is in a particular clinical state, e.g. menopausal status, pregnancy status.

Other microscopically identifiable abnormalities relevant to the diagnosis.

An ancillary study performed using a cytogenetic procedure.

The examination of a single cell type, as often found in fluid specimens.

Diagnosis details relevant to a radiation oncology treatment summary form.

The extent to which the tumour resembles the tissue of origin.

The identifying, versioning and descriptive details of a document.

The performance status of a patient as defined by the Eastern Cooperative Oncology Group (ECOG).

An ancillary study to test for the presence of oestrogen receptors.

An ancillary study performed using flow cytometry.

A section used to support compositions for gastrointestinal cancers.

Sections that are common across multiple forms.

An observation about a gene, gene sequence, or panel of genes / gene sequences.

The grading of a sarcoma using the French Federation of Cancer Center’s grading system (FNCLCC = Fédération Nationale des Centres de Lutte contre le Cancer).

The grading of a neuroendocrine tumour using the WHO neuroendocrine tumour grading system.

The grading of a malignant neoplasm using the WHO malignant high low system.

An ancillary study to test for the presence of tyrosine-protein kinase erbB-2 receptors.

A molecular study to test for the presence of HER2 gene amplification.

A laboratory test of blood formation and blood disorders.

A facility at which healthcare is provided.

The main identifying details of a healthcare facility.

A person who is directly or indirectly involved in the provision of healthcare or related services.

The main identifying details of a healthcare practitioner.

The distance from the bottom of the patient’s feet to the top of their head, while they are standing.

The degree of differentiation of a tumour, e.g. the extent to which a tumour resembles the normal tissue at the site.

A categorisation of the physical features of the cells and their surrounding tissue as seen under a microscope.

An image of the patient’s tumour, specimen, or radiology.

An ancillary study that is performed using immunohistochemistry.

The administrative details on an investigation report.

The administrative details on an investigation request, including the requester, performer, and type of investigation requested.

The percentage of cells in a tumour sample that are actively dividing.

A lymph node sample to be used for analysis.

Whether or not lymph nodes are involved in a cancer diagnosis and if so relevant information about their involvement.

Whether or not lymph nodes are involved in a gastrointestinal cancer diagnosis and if so relevant information about their involvement.

Information about any lymph node specimens taken in addition to the main breast specimen.

Whether or not lymphovascular invasion of the cancer is present.

Observations on a specimen that are visible to the naked eye, as documented on a soft tissue biopsy histopathology report.

Observations on a specimen that are visible to the naked eye, as documented on a soft tissue histopathology report.

An observation on a specimen that is visible to the naked eye.

Observations on a specimen that are visible to the naked eye, as documented on a colorectal diagnostic histopathology report.

Observations on a specimen that are visible to the naked eye, as documented on a colorectal resection histopathology report.

Details about a particular margin on a resected specimen.

The status of the tissue on the margin of a resected specimen.

A medical condition that is known to be present in the patient.

An indication of whether the patient is pre or post menopausal.

Observations on a specimen that are only visible under a microscope, as documented on a soft tissue biopsy histopathology report.

Observations on a specimen that are only visible under a microscope, as documented on a soft tissue histopathology report.

The examination of tissues and/or cells under a microscope to diagnose and study diseases of the tissues.

Observations on a specimen that are only visible under a microscope, as documented on a colorectal histopathology report.

Observations on a specimen that are only visible under a microscope, as documented on a colorectal diagnostic histopathology report.

Observations on a specimen that are only visible under a microscope, as documented on a colorectal endoscopic resection histopathology report.

Observations on a specimen that are only visible under a microscope, as documented on a colorectal metastectomy histopathology report.

Observations on a specimen that are only visible under a microscope, as documented on a colorectal operative resection histopathology report.

Observations on a specimen that are only visible under a microscope, as documented on a colorectal resection histopathology report.

The number of mitotic figures per high-power field (HPF) found in the most mitotically active part of the tumour.

An ancillary study performed using a molecular testing procedure.

An address or location using NZ CIQ address profile format.

The electronic contact details required eg: for person or organisation

The name of a person, e.g. patient or healthcare provider, structured following the HISO naming standards.

The percentage of tumour volume with necrosis.

An assessment of the response to neoadjuvant therapy.

An assessment of the response to neoadjuvant therapy for a soft tissue tumour.

A summary of the patient’s neoadjuvant treatment status and details.

A measurement or assertion made about a patient, e.g. a clinical assessment, imaging results, or laboratory finding.

The pathological stage classification of distant metastasis, based on diagnostic work-up from clinical staging combined with operative findings and pathological review of specimens.

The pathological stage classification of regional lymph nodes, based on diagnostic work-up from clinical staging combined with operative findings and pathological review of specimens.

An ancillary study to test for the presence of progesterone receptors.

The pathological stage classification of the primary tumour, based on diagnostic work-up from clinical staging combined with operative findings and pathological review of specimens.

Pathological TNM staging for invasive carcinoma of the breast, and ductal carcinoma in situ of the breast.

Pathological TNM staging using the AJCC staging manual.

Pathological TNM staging for soft tissue sarcomas and related cancers.

Pathological TNM staging using a AJCC staging manual for a soft tissue tumour.

The administrative details on a pathology report.

The administrative details on a pathology test request, including tissue consent details.

Identifying and demographic details about the patient.

A short summary of the main identifying details for a patient, as seen on a CanShare form.

A short summary of the main identifying details for a patient, as seen on a pathology form.

Whether or not perineural invasion of the cancer is present.

Relevant details about previous biopsy results for the breast tumour.

A relevant medical condition that the patient had previously.

A relevant histological type of any previous specimen.

A primary cancer condition that is diagnosed in the patient (either clinically or pathologically). For solid cancers, this is the original or first neoplasm in the body. For haematologic cancers, this is the original cancer type in the body. This also includes cancers of uncertain origin or behaviour.

An action that is or was performed on or for a patient, e.g. surgical procedure, biopsy procedure.

Relevant details about the procedure during which the small diagnostic specimen was collected, as documented on a colorectal small diagnostic histopathology request.

Relevant details about the procedure during which the endoscopic resection specimen was collected, as documented on a colorectal histopathology endoscopic resection request.

Relevant details about the metastectomy procedure during which the specimen was collected, as documented on a colorectal histopathology metastectomy request.

Relevant details about the procedure during which the operative resection specimen was collected, as documented on a colorectal histopathology operative resection request.

Relevant details about the procedure during which the specimen was collected, as documented on a colorectal histopathology request.

Relevant details about the procedure during which the resection specimen was collected, as documented on a colorectal histopathology resection request.

A prediction of the likely disease outcome based on a selected set of prognostic factors.

A section used to support compositions for radiation oncology.

A single course of radiation therapy.

The radiologic imaging used to examine parts of the body to aid diagnosis and guide treatment plans.

The radiologic imaging used to examine the breasts to aid diagnosis and guide treatment plans.

The pathway by which the patient was referred for the given service.

Referral pathway details for colorectal diagnostic services.

Referral pathway details for a colorectal resection.

Referral pathway details for colorectal screening services.

Referral pathway details for colorectal surveillance services.

Referral pathway details for colorectal services.

The administrative details on a clinical report.

The administrative details on a service request, including the requester, requested service provider and date of request.

A single regimen therapy for systemic anti-cancer therapy.

A datagroup used to bundle multiple datagroups together for organising into a section of a composition.

A measurement of the concentration of creatinine in the blood, used to determine renal function.

A histopathology report form for soft tissue tumours from a biopsy specimen.

A histopathology request form for soft tissue tumours from a biopsy specimen.

A section used to support compositions for soft tissue and/or bone cancers.

A sample to be used for analysis.

Relevant details about the specimen in a breast histopathology composition.

Relevant specimen information in a breast resection histopathology composition.

Relevant specimen information in a breast small diagnostic histopathology composition.

Relevant details about the specimen in a colorectal histopathology request.

Relevant details about the specimen in a colorectal screening histpathology request.

Relevant details about the specimen in a colorectal surveillance or diagnostic histopathology request.

Relevant details about the biopsy specimen in a soft tissue histopathology composition.

Relevant details about the specimen in a soft tissue histopathology composition.

Relevant details about the resection specimen in a soft tissue histopathology composition.

Details about the blocking preparation done for each specimen.

An individual container (e.g. a specific tube) in which the specimen is placed.

The size of the specimen measured in one or more dimensions.

Orientation markers of a tissue sample (used for excision/resection specimens).

A reference to a specimen collected from a patient.

Relevant details about the patient’s tumour on a specimen, as documented on a colorectal histopathology request.

Details about how far and where the cancer has spread.

Details about any spread into adjacent organs of the primary tumour.

Details about any spread into regional locations of the primary tumour.

Details about any distant metastasis of the primary tumour.

Staging information that describes the prognosis of the specific disease at a given time in the patient’s cancer journey.

TNM staging using the AJCC staging manual, which is relevant to a radiation oncology treatment summary form.

A medical procedure performed by surgeon.

An observation of the T, N, or M category stage of a cancer.

A predetermined group of laboratory tests used in the diagnosis and treatment of disease.

Any histologic changes (e.g. shrinkage of tumour cells) seen following therapy.

Details about the treatment course(s) relevant to a radiation oncology treatment summary form.

The administrative details on a treatment request.

An abnormal change and/or damage in a body structure or tissue.

Details about the patient’s tumour, as documented on a colorectal metastectomy histopathology request.

Relevant details about the patient’s tumour, as documented on a colorectal histopathology report.

Details about the patient’s tumour, as documented on a colorectal resection histopathology request.

Relevant details about the tumour in a soft tissue biopsy histopathology composition.

Relevant details about the tumour in a soft tissue histopathology composition.

A prognostic biomarker that scores the number of tumour buds (i.e. isolated single cancer cells or clusters of up to 4 cancer cells located at the invasive tumour front).

The deepest layer in which the tumour is present.

The size of the tumour measured in one or more dimensions.

Information about one or more tumours found in a single organ.

The result of an observation on a tumour or lesion.

A reference to a lesion/tumour for a patient.

Information about the tumour’s direct penetration into surrounding tissue.

Relevant details about the tumours in a breast histopathology composition.

The percentage of residual viable tumour after neoadjuvant therpay.

A measurement of the patient’s weight.

The measured or calculated surface area of the patient’s body.

A histopathology request form for colorectal small diagnostic symptomatic specimens.

A histopathology request form for colorectal metastectomy specimens.

The distance from the bottom of the patient’s feet to the top of their head, while they are standing.

A measurement or assertion made about a patient, e.g. a clinical assessment, imaging results, or laboratory finding.

Identifying and demographic details about the patient.

A classification of the ethnicity of an individual person as self-identified by the person

This indicator denotes that the person’s name information is to be held ‘in confidence’

A classification of the person’s sex characteristics such as chromosomes, hormones and reproductive organs (Stats NZ Statistical standard for gender, sex, and variations of sex characteristics).

The name of the suburb or district within a city/town.